Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL891032 | 0.78 | ALDH1A3 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL891040 | 0.78 | — | — | |
| SCHEMBL891038 | 0.76 | — | — | |
| SCHEMBL890648 | 0.75 | MTNR1A (0.40) | ALDH1A1KMT2A | |
| SCHEMBL17911622 | 0.74 | CA12 (0.37) | CA12CA1CA2CA7CA9 | |
| SCHEMBL890868 | 0.74 | KMT2A (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL891205 | 0.73 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL890932 | 0.72 | — | — | |
| SCHEMBL10749835 | 0.71 | HDAC1 (0.43) | ELANE | |
| SCHEMBL20653201 | 0.68 | TDP1 (0.48) | ALDH1A1TDP1KMT2APARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4679147-A1 | MULTILAYER BODY, OPTICAL ARTICLE, COATING LAYER-CONTAINING MULTILAYER BODY, LENS, EYEGLASSES, AND FILM FOR WINDOWS | TOKUYAMA CORPORATION (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20250355282-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-11-20 | — | — | US | disclosed |
| US-20250257162-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-4582459-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | Kureha Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4582463-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | Kureha Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4560367-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-05-28 | — | — | EP | disclosed |
| EP-4516823-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-03-05 | — | — | EP | disclosed |
| WO-2024185580-A1 | MULTILAYER BODY, OPTICAL ARTICLE, COATING LAYER-CONTAINING MULTILAYER BODY, LENS, EYEGLASSES, AND FILM FOR WINDOWS | 株式会社トクヤマ | 2024-09-12 | — | — | WO | disclosed |
| US-20040141230-A1 | Optical materials having good ultraviolet absorbability and method for producing them | KOSAKA MASAHISA (JP) | 2004-07-22 | — | — | US | disclosed |
| EP-1422197-A1 | DISPERSED INGREDIENT HAVING METAL−OXYGEN | NIPPON SODA CO., LTD. (JP) | 2004-05-26 | — | — | EP | disclosed |
| US-6673888-B2 | PLASTIC LENSES | HOYA CORPORATION (JP) | 2004-01-06 | — | — | US | disclosed |
| US-20020132954-A1 | Optical materials having good ultraviolet absorbability and method for producing them | KOSAKA MASAHISA (JP) | 2002-09-19 | — | — | US | disclosed |
| US-6448304-B1 | POLYURETHANE, POLYTHIOURETHANE OR DIETHYLENE GLYCOL BISALLYLCARBONATE POLYMER; DIPPING IN SOLUTION CONTAINING A DIBENZOYLMETHANE OR A BENZOTRIZOLE COMPOUND; PLASTIC LENS FOR SPECTACLES WHICH ABSORBS ULTRAVIOLET RAYS; LOW YELLOWNESS | HOYA CORPORATION (JP) | 2002-09-10 | — | — | US | disclosed |
| US-6441119-B1 | POLYMERIZING A PLASTIC LENS MONOMER SUCH AS A DIETHYLENE GLYCOL, BISALLYL CARBONATE MIXED WITH THE UV ABSORBENT 2-(2-HYDROXY-4-OCTYLOXYPHENYL)-BENZOTRIAZOLE; NONYELLOWING; EYEGLASSES | HOYA CORPORATION (JP) | 2002-08-27 | — | — | US | disclosed |
| EP-1085349-A2 | Plastic lenses having good ultraviolet absorbability, and method for the production thereof | HOYA CORPORATION (JP) | 2001-03-21 | — | — | EP | disclosed |
| EP-1085348-A2 | Plastic lenses of good ultraviolet absorbability for spectacles and method for producing them | HOYA CORPORATION (JP) | 2001-03-21 | — | — | EP | disclosed |
| US-5955206-A | POLYTHIOETHERS AND ACRYLATE OR VINYL GROUPS FOR CURING TO FORM OPTICAL LENSES | MITSUI CHEMICALS, INC. (JP) | 1999-09-21 | — | — | US | disclosed |
| EP-0742244-A2 | Durable polysulfide composition for optical material | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | CROCC, WASF2, DCXR | CA12 3838/4885CA1 3940/4885CA2 4353/4885 |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | EHMT1, EHMT2, ASH2L | CA12 563/4885CA1 78/4885CA2 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.